Description: Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Shenzhen SiMeiQuan Biotechnology Co., Ltd. was established in 2014, is located in the convenient transportation #2 New District Road, Minzhi Street, Longhua New District, Shenzhen, China. As the new show the chemical industry, the company focused on research, development, production and sale of chemical and pharmaceutical products. Headquarters and research base set up in the scenic Shouyi innovative biochemical Industrial Park and has offices in Shenzhen, Zhuhai, Guangzhou, Zhongshan, Zhuzhou a...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 51 - 100 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$2.5 Million - US$5 Million
Year Established: 1999
Number of Employees: 51 - 100 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
China
